CoChat
Sign Up
Cited by 674Psychedelics and Drug StudiesPosttraumatic Stress Disorder ResearchElectroconvulsive Therapy Studies

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Open access
Mithoefer, Michael C, Wagner, Mark T, Mithoefer, Ann T, Jerome, Lisa, Doblin, Rick·2011·Journal of Psychopharmacology
DOI 10.1177/0269881110378371PMC PMC3122379
Open this paper in CoChat — free account

Abstract

Case reports indicate that psychiatrists administered ±3,4-methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before recreational use of MDMA as 'Ecstasy' resulted in its criminalization in 1985. Over two decades later, this study is the first completed clinical trial evaluating MDMA as a therapeutic adjunct. Twenty patients with chronic posttraumatic stress disorder, refractory to both psychotherapy and psychopharmacology, were randomly assigned to psychotherapy with concomitant active drug (n = 12) or inactive placebo (n = 8) administered during two 8-h experimental psychotherapy sessions. Both groups received preparatory and follow-up non-drug psychotherapy. The primary outcome measure was the Clinician-Administered PTSD Scale, administered at baseline, 4 days after each experimental session, and 2 months after the second session. Neurocognitive testing, blood pressure, and temperature monitoring were performed. After 2-month follow-up, placebo subjects were offered the option to re-enroll in the experimental procedure with open-label MDMA. Decrease in Clinician-Administered PTSD Scale scores from baseline was significantly greater for the group that received MDMA than for the placebo group at all three time points after baseline. The rate of clinical response was 10/12 (83%) in the active treatment group versus 2/8 (25%) in the placebo group. There were no drug-related serious adverse events, adverse neurocognitive effects or clinically significant blood pressure increases. MDMA-assisted psychotherapy can be administered to posttraumatic stress disorder patients without evidence of harm, and it may be useful in patients refractory to other treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881110378371

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 14

  1. Breslau N, 2001, J Clin Psychiatry, 62, 16
  2. Cloitre M, 2009, CNS Spectr, 14, 32
  3. Committee on Treatment of Posttraumatic Stress Disorder, Institute of Medicine, 2008, Posttraumatic stress disorder: an assessment of the evidence
  4. Derogatis LR, 1994, SCL-90-R: Administration, Scoring and Procedures Manual
  5. First MB, 1997, Structured clinical interview for Axis II DSM-IV disorders: Patient Edition (SCID II)
  6. First MB, 1994, Structured clinical interview for Axis I DSM -IV disorders: Patient Edition (SCID-I/P)
  7. Grof S, 2000, Psychology of the Future
  8. Ipser J, 2006, S Afr Med J, 96, 1088
  9. Metzner R, 2001, Ecstasy: the complete guide, 182
  10. Ogden PKM, 2006, Trauma and the body
  11. Pahnke WN, 1971, Int J Clin Pharmacol, 4, 446
  12. Stein DJ, 2009, CNS Spectr, 14, 25
  13. 10.1038/sj.npp.1395197 · DOI · Paper page
  14. Wilbarger P, 1997, Sensory defensiveness and related social/emotional and neurological problems

Cited by

Sorted by citations

Items 401–500 of 671

Related

See all

Metadata

Authors
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R.
Affiliations
  • Private Practice of Psychiatry and Clinical Research, Mount Pleasant SC, USA.
  • Medical University of South Carolina (US)
  • Multidisciplinary Association for Psychedelic Studies (US)
Corresponding author
Mithoefer, Michael C
ORCID
Venue
Journal of Psychopharmacology
Publisher
SAGE Publications
Published
2010-07-19
Volume
25
Issue
4
Pages
439-452
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
DOI
10.1177/0269881110378371
PMC
PMC3122379
OpenAlex
W2089149909
Cited by
674
References
67
Citations by year
2026: 30 · 2025: 36 · 2024: 75 · 2023: 49 · 2022: 52 · 2021: 41 · 2020: 61 · 2019: 62 · 2018: 59 · 2017: 45 · 2016: 28 · 2015: 27 · 2014: 23 · 2013: 44 · 2012: 26
FWCI
29.42
Type
journal article
Language
en
Update notices
correction (2011-06-01)
Open access
Licence
Locations
  • Journal of Psychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
MDMA-assisted psychotherapy, MDMA, 3,4-methylenedioxymethamphetamine, post-traumatic stress disorder, treatment-resistant PTSD, chronic PTSD, psychedelic therapy, Clinician-Administered PTSD Scale, adverse events, neurocognitive effects, blood pressure
MeSH terms
Adult, Aged, Double-Blind Method, Fear, Female, Humans, Male, Middle Aged, Music Therapy, Pilot Projects, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Stress Disorders, Post-Traumatic, Treatment Outcome, Serotonin Agents, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review